Erythropoiesis and iron kinetics.

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89

Mutations and prognosis in primary myelofibrosis. Leukemia (2013) 3.13

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Leukemia (2007) 2.61

Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood (1997) 2.31

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia (2010) 2.30

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia (2010) 2.23

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia (2010) 2.13

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant (2009) 2.03

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia (2013) 1.97

Guidelines for the use of recombinant human erythropoietin. Haematologica (1995) 1.94

Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia (2008) 1.77

Flexible guideline-based patient careflow systems. Artif Intell Med (2001) 1.77

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70

A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69

Outdoor air pollution, climatic changes and allergic bronchial asthma. Eur Respir J (2002) 1.64

A case study in ontology library construction. Artif Intell Med (1995) 1.60

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol (1998) 1.55

A Web-based system for the intelligent management of diabetic patients. MD Comput (1997) 1.53

Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet (1994) 1.52

Guideline-based careflow systems. Artif Intell Med (2000) 1.51

Adaptive controllers for intelligent monitoring. Artif Intell Med (1995) 1.51

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia (2010) 1.51

Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev (2011) 1.50

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis. Am J Med (2001) 1.49

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49

An observational study of venoplasty in patients with multiple sclerosis. Can J Neurol Sci (2013) 1.46

Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia (2006) 1.45

NEOANEMIA: a knowledge-based system emulating diagnostic reasoning. Comput Biomed Res (1990) 1.41

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40

Evidence-based careflow management systems: the case of post-stroke rehabilitation. J Biomed Inform (2002) 1.29

Protocol-based reasoning in diabetic patient management. Int J Med Inform (1999) 1.28

Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27

MPN-associated myelofibrosis (MPN-MF). Leuk Res (2010) 1.25

The M2DM Project--the experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Methods Inf Med (2006) 1.22

A patient workflow management system built on guidelines. Proc AMIA Annu Fall Symp (1997) 1.21

Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br J Haematol (1998) 1.20

Mining biomedical time series by combining structural analysis and temporal abstractions. Proc AMIA Symp (1998) 1.20

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood (1996) 1.20

Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol (1995) 1.19

Splenomegalic immunocytoma with circulating hairy cells. Report of eight cases and revision of the literature. Haematologica (1986) 1.19

Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17

A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia (2009) 1.15

The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis. Haematologica (1999) 1.14

Supporting tools for guideline development and dissemination. Artif Intell Med (1998) 1.10

Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology (2001) 1.09

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia (2005) 1.09

Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study. Respir Med (2007) 1.09

What are RBC-transfusion-dependence and -independence? Leuk Res (2010) 1.09

Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem (1999) 1.08

Intelligent analysis of clinical time series: an application in the diabetes mellitus domain. Artif Intell Med (2000) 1.07

Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion (1993) 1.05

Deciding when to intervene: a Markov decision process approach. Int J Med Inform (2000) 1.04

Clinical, laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol (1990) 1.03

Leukemia risk models in primary myelofibrosis: an International Working Group study. Leukemia (2012) 1.01

Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans. Blood (1985) 1.01

Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00

Performance characteristics of Hemox-Analyzer for assessment of the hemoglobin dissociation curve. Haematologica (1996) 1.00

The role of outdoor air pollution and climatic changes on the rising trends in respiratory allergy. Respir Med (2001) 1.00

A framework for building cooperative software agents in medical applications. Artif Intell Med (1999) 1.00

The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler (2005) 0.99

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J (2003) 0.99

Mucoceles in the paranasal sinuses involving the orbit: CT signs in 43 cases. Neuroradiology (1982) 0.99

Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet (1999) 0.98

Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. Br J Haematol (1996) 0.98

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol (1998) 0.97

Myelodysplastic syndromes: recent advances. Haematologica (2001) 0.97

Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood (1999) 0.96

Qualitative models and fuzzy systems: an integrated approach for learning from data. Artif Intell Med (1998) 0.95

Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci (2005) 0.95

Apoptosis: biological and clinical aspects. Haematologica (2004) 0.94

Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94

A performance evaluation of the expert system ANEMIA. Comput Biomed Res (1988) 0.93

Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93

Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92

Ontology and terminology servers in agent-based health-care information systems. Methods Inf Med (1997) 0.92

CD34-positive cells: biology and clinical relevance. Haematologica (1995) 0.92

A mathematical model of iron metabolism. J Math Biol (1982) 0.92

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Blood (1987) 0.92

Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J Autoimmune Dis (2005) 0.91

Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. Blood (1994) 0.91

A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica (2000) 0.91

Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol (2001) 0.91

Respiratory allergic diseases induced by outdoor air pollution in urban areas. Monaldi Arch Chest Dis (2003) 0.90

Inadequate erythropoietin response to anemia: definition and clinical relevance. Ann Hematol (1994) 0.90

The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can J Neurol Sci (2008) 0.90

Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia (1993) 0.89

Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia. Scand J Haematol (1983) 0.89

A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Int Med Res (1989) 0.89